Clinical Trials in Arizona

Showing 9121-9140 of 14,395 trials

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

NCT00688415

This is a multi-center, Phase I study of a new investigational drug, VTX-2337, that may stimulate the immune system to help fight cancer. The purpose of the study is to assess the safety of the investigational drug and to identify the highest dose that is well-tolerated. The pharmacology of VTX-2337 will also be evaluated.

Advanced Solid TumorsLymphoma

Celgene33 participantsStarted Nov 2008

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States

COMPLETEDPhase 231 miles

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

NCT02288559

This multicenter, randomized, single-masked, sham injection-controlled study will investigate the exposure-response and safety of lampalizumab administered intravitreally every 2 weeks (Q2W) or every 4 weeks (Q4W) for 24 weeks in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). A safety run-in assessment will be conducted prior to initiating enrollment in the randomized study.

Geographic Atrophy

Genentech, Inc.96 participantsStarted Mar 2015

Mesa, Arizona, United States • Tucson, Arizona, United States • Springdale, Arkansas, United States +33 more locations

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Find Trials by Condition in Arizona

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

A Study in Second Line Metastatic Colorectal Cancer

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Study of Ramucirumab in Ovarian Cancer

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

A Study in Advanced Solid Tumors

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab